Good Pharma, Bad Pharma

What does the global pharmaceutical industry have to gain from the roll-out of vaccines?

Household names like Pfizer are their own kettle of fish, but for the AstraZenecas and Novavaxs of the world, it’s a rare coalition of public goodwill and government assistance that could fundamentally change the industry moving forward.

But, when a global health crisis greases the wheels of the world’s pharmaceutical regulatory bodies; what happens when the virus is controlled?